Rhoen Klinikum special situation – Nice suprise
Rhoen Kliniikum was a special situation, where I took a half position last year. The simple idea was that the failed take over attempt by Fresenius would “revive” at some point in time plus the stock was solid and relatively cheap.
Now it seems that this is paying of sooner than expected. In today’s shareholder meeting, the existing poison pill which killed the take over was effectivly removed according to this article:
The existing requirement that 90% of shareholders have to approve a merger was changed into 75% requirement. This means that the current players which tried to block the take over by Fresenius (Braun and Asklepius, 5% each) either will have to give up or buy some more shares.
Both should e very positive for the shareprice.
AFter hour, the shareprice jumped already ~20%:
If the price gets near the old offer (22,50 EUR), I would sell the position.
Note to myself: Check TNT Express again…..